What healthcare companies should consider as they enter 2024

2024 will see two billion voters heading to the polls in over 50 elections around the world. This wave of electoral activity comes at a time when the world is grappling with the complex challenges of geopolitical conflict, rising inflation, and a higher cost of living.

The outcomes of these elections will leave a lasting impact, particularly in shaping healthcare policies across different nations. The decisions made by newly elected leaders and governments will have a ripple effect on how other countries navigate and address the pressing healthcare issues of our time, including access to medical care, public health strategies, and the financing of healthcare systems.

The big picture

In the United States, the 2024 presidential election and the outcome of the Biden administration’s efforts to lower drug prices will not only shape domestic landscape but also set a precedent for other countries. The possible re-election of Prime Minister Narendra Modi in India, a key player in global drug manufacturing and exports, could sustain the current pro-business environment, potentially enhancing India’s role as a major supplier in the global pharmaceutical chain. In Taiwan, the newly elected Lai Ching-te from the Democratic Progressive Party could mark the start of a shift in pharmaceutical trade and international collaboration, particularly in relation to China.

What core communications principles are needed throughout 2024?

With all of this change on the horizon, the role of effective, purpose-driven communication will become even more important for healthcare and pharmaceutical companies as they navigate the year ahead. Keep reading for our take on what to prioritise.

Scientific data that tells a story

During a year of tightened budgets and scrutinised healthcare spending, there’s a need to translate complex scientific data into narratives that make the case for the value of innovation on society. A storytelling approach is essential to convey the implications of new drugs and scientific findings to the public, healthcare professionals, and policymakers.

Strong media relations with key healthcare journalists

Having great relationships with key healthcare journalists is important during uncertain periods. These relationships are crucial for building and maintaining your reputation, and can come in especially useful if a policy change is about to impact patients. Journalists can be conveners of dialogue between the public, policymakers and pharmaceutical companies, ensuring that complex information is distilled in a way that patients understand.

Access to industry intelligence and on the ground insights

Companies should develop a nuanced understanding of the local implications of global decisions. A deepened perspective and the close monitoring of news and policy changes will ensure companies can quickly respond to or pre-empt changes that could impact their operations.

Powerful and consistent messaging

Companies must maintain a unified message across all channels, and it should be adaptable in order to resonate with regional audiences. In Asia, this involves tailoring communication strategies to align with local nuances and market dynamics. Messaging must reflect a deep understanding of local healthcare systems, regulations, and the huge variation in patient needs around the region, while still upholding the company’s core values and global objectives.

You don’t need to do all of this alone. As healthcare specialists, Spurwing has the expertise and understanding you need to turn 2024 into an opportunity to influence and lead from the front, even amidst uncertainty. Get in touch with us to learn more about how we can work with you as a trusted partner this year: hello@spurwingcomms.com